MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles.

scientific article

MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/B809645G
P698PubMed publication ID19156273
P5875ResearchGate publication ID23804106

P50authorJosé M Domínguez-VeraQ42728352
Natividad GalvezQ59509779
P2093author name stringAlessandro Lascialfari
Giulio Poletti
Massimo Marinone
Maurizio Corti
Purificación Sánchez
Elsa Valero
P2860cites workGadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsQ28212229
High proton relaxivity for gadolinium oxide nanoparticlesQ28257779
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imagingQ28295791
The ferritins: molecular properties, iron storage function and cellular regulationQ28609366
Catalytic effects of apoferritin interior surface residues on water proton exchange in lanthanide complexes.Q31088650
(1)H relaxivity of water in aqueous suspensions of Gd(3+)-loaded NaY nanozeolites and AlTUD-1 mesoporous material: the influence of Si/Al ratio and pore sizeQ31116763
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imagingQ33278085
Mineralization in ferritin: an efficient means of iron storageQ33707673
Size-selective olefin hydrogenation by a Pd nanocluster provided in an apo-ferritin cageQ34318800
Superparamagnetic gadonanotubes are high-performance MRI contrast agentsQ34439633
Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.Q34918614
Metallic colloid nanotechnology, applications in diagnosis and therapeuticsQ36172824
Synthesis and characterisation of Gd2O3 nanocrystals functionalised by organic acidsQ46520271
Preparation of Cu and CuFe Prussian Blue derivative nanoparticles using the apoferritin cavity as nanoreactor.Q50483815
Nanoparticles of Prussian blue ferritin: a new route for obtaining nanomaterials.Q50492351
Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging.Q53439737
Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin ProbeQ58831586
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
P304page(s)800-804
P577publication date2008-11-28
P1433published inDalton TransactionsQ282900
P1476titleMRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles

Reverse relations

cites work (P2860)
Q38686537Biomimetic and Bioinspired Synthesis of Nanomaterials/Nanostructures.
Q31132658Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy
Q46625330Enrichment and characterization of ferritin for nanomaterial applications.
Q36948081Ferritins as nanoplatforms for imaging and drug delivery
Q87957089Functional ferritin nanoparticles for biomedical applications
Q57183679Magnetism and spin dynamics of novel encapsulated iron oxide superparamagnetic nanoparticles
Q26849668Metalloprotein-based MRI probes
Q34138376Mn loaded apoferritin as an MRI sensor of melanin formation in melanoma cells
Q61337229Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model
Q30575680PEG-capped, lanthanide doped GdF3 nanoparticles: luminescent and T2 contrast agents for optical and MRI multimodal imaging
Q34334874Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory
Q45858764Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin
Q34065934The sedimentation properties of ferritins. New insights and analysis of methods of nanoparticle preparation.
Q36693096Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles

Search more.